This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nihon Medi-Physics Company, Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Marino Maemura: Innovator in Medical Composition
Introduction
Marino Maemura is a notable inventor based in Sodegaura, Japan. He has made significant contributions to the field of medical compositions, particularly in enhancing the water-solubility of peptides and their metal-labeling efficiency. His innovative approach has the potential to improve medical diagnostics and treatments.
Latest Patents
Marino Maemura holds 1 patent for his invention titled "Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide." This patent describes a method of dissolving a basic organic compound in an aqueous solvent to enhance the solubility of peptides. This advancement allows for metal-labeling without the need for heating, making it a valuable asset in medical applications such as image diagnosis and radiotherapy.
Career Highlights
Marino Maemura is associated with Nihon Medi-Physics Company, Limited, where he continues to develop innovative solutions in the medical field. His work focuses on creating compositions that can be utilized in various medical applications, showcasing his commitment to advancing healthcare technology.
Collaborations
Marino collaborates with talented individuals such as Takayoshi Kawaguchi and Ikuya Seki, who contribute to his research and development efforts. Their teamwork enhances the potential for groundbreaking innovations in medical compositions.
Conclusion
Marino Maemura's contributions to medical compositions demonstrate his dedication to improving healthcare through innovation. His patented work has the potential to significantly impact medical diagnostics and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile